Генная терапия диабетической нейропатии

Генная терапия диабетической нейропатии

Автор: Деев Р.В., Плакса Игорь Леонидович, Матвеев С.А.

Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center

Рубрика: Обзоры литературы

Статья в выпуске: 1 т.10, 2015 года.

Бесплатный доступ

Короткий адрес: https://sciup.org/140188386

IDR: 140188386

Список литературы Генная терапия диабетической нейропатии

  • Левин О.С. Полиневропатия: клиническая лекция для врачей. -М.: РМАПО, 2001. -26 с.
  • Ajroud-Driss S. Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy/S. Ajroud-Driss, M. Christiansen, J. A. Allen//Molecular Therapy. -2013. -Vol. 21. -P. 1279-1286.
  • Bouard D. Viral vectors: from virology to transgene expression/D. Bouard, N. Alazard-Dany, F.L. Cosset//British j. of pharmacology. -2009. -Vol. 157. -P. 153-165.
  • Chattopadhyay M. HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy/M. Chattopadhyay //Gene ther. -2005. -Vol. 18. -P. 1377-84.
  • Chattopadhyay M. Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer/M. Chattopadhyay //Diabetologia. -2007. -Vol. 7. -P. 1550-8.
  • Chattopadhyay M. Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons/M. Chatto-padhyay //Brain. -2009. -Vol. 132. -P. 879-88.
  • Consensus statement; report and recommendations of the San Antonio Conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology//Diabetes care. -1988. -Vol. 11, №7. -P. 592-597.
  • Dent C. Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy/C. Dent //Diabetes. -2006. -Vol. 55, № 6. -P. 1847-54.
  • Edward A.B. Multiple applications for replication-defective herpes simplex virus vectors/A. B. Edward //Stemm cells. -2001. -Vol. 19. -P. 358-377.
  • Erbayraktar S. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo/S. Erbayraktar //Proc. nat. acad. sci. -2003. -Vol. 100. -P. 6741-6.
  • Ehrenreich H. Erythropoietin therapy for acute stroke is both safe and beneficial/H. Ehrenreich //Mol. med. -2002. -Vol. 8. -P. 495-505.
  • Florian P.T. The spectrum of diabetic neuropathy. -Saint Louis University.: School of Medicine Saint Louis, 2005. -p. 15.
  • Frykberg R.G. Diabetes foot disorders. A clinical practice guidline/R.G. Frykberg//J. Foot and Ankle Surgery. -2006. -Vol. 45. -P. 62-66.
  • Fink D.J. Targeted drug delivery to the peripheral nervous system using gene therapy/D. J. Fink, D. Wolfe, M. Mata,//Neurosci. Lett. -2012. -Vol. 11. P. 85-89.
  • Fink D.J. Gene Therapy for Pain: Results of a Phase I Clinical Trial/D. J. Fink //Ann. Neurol. -2011. -Vol. 70. -P. 1-11.
  • Goinz W.F. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction/W.F. Goins //J. Urol. -2001. -Vol. 165. -P. 1748-54.
  • Ghezzi P. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury/P. Ghezzi //Proc. Natl. Acad. Sci. -2000. -Vol. 97. -P. 526-31.
  • International Diabetes Federation. IDF Diabetes Atlas, 6th edn. Brussels, Belgium. Available from: http://www.idf.org/diabetesatlas/
  • Koike H. Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene/H. Koike //The Faseb. Journal. -2003. -Vol. 17, №6. -P. 779-81.
  • Kennel P. Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies/P. Kennel //Human Gene Therapy. -2001. -Vol. 18. -P. 2237-2249.
  • Kennel P. Viral and non-viral Gene Therapy partially prevents experimental cisplatin-induced neuropathy/P. Kennel, P.F. Pradat, S. Naimi-Sadaoui//Gene Therapy. -2002. -Vol. 9. -P. 1333-1337.
  • Lai C.L. Peripheral gene transfer of glial cell-derived neurotrophic factor ameliorates neuropathic deficits in diabetic rats/C.L. Lai //Hum. Gene Ther. -2009. -Vol. 7. -P. 715-27.
  • Mata M. Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced Diabetes in the mouse/M. Mata //Diabetes. -2002. -Vol. 51, №7. -P. 2227-32.
  • Mata M. Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin/M. Mata, Z. Wu, D. J. Fink//Mol. Ther. -2011. -Vol.19, № 2. -P. 310-7.
  • Mata M. Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter element/M. Mata, Z. Wu, D.J. Fink//Gene Ther. -2012. -Vol. 19, № 11. -P. 1107-13.
  • Matsuka Y. HSV-1-mediated NGF delivery delays nociceptive deficits in genetic model of diabetic neuropathy/Y. Matsuka //Exp. Neurol. -2006. -№ 198. -P. 260-70.
  • Palazzuoli A. The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions/A. Palazzuoli, //Ther. Clin. Risk Manag. -2014. -Vol. 10. -P. 641-50.
  • Qiao C. Efficient retrograde transport of adeno-associated virus type 8 to spinal cord and dorsal root ganglion after vector delivery in muscle/C. Qiao //Hum. Gene Ther. -2010. -Vol. 21. -P. 87-97.
  • Schratzberger P. Reversal of experimental diabetic neuropathy by VEGF gene transfer/P. Schratzberger //J. Clin. Invest. -2001. -Vol. 107. -P. 1083-92.
  • Simovic D. Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: A randomized, double-blinded trial/D. Simovic //Ann. Neuro. -2009. -Vol. 65. -P. 386-393.
  • Sondell M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor/M. Sondell //Eur. J. Neurosci. -2000. -Vol. 12. -P. 4243-54.
Еще
Статья
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp